Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 1910-1916

  Guermonprez, Pierre ^a   Ladant, Daniel ^a   Karimova, Gouzel ^a   Ullmann, Agnes ^a   Leclerc, Claude ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CD8 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERTUSSIS TOXIN; PROTEASOME;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL TRANSLOCATION; BORDETELLA PERTUSSIS; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; ENDOCYTOSIS; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ATP-BINDING CASSETTE TRANSPORTERS; BREFELDIN A; CALCIUM; CELL LINE; CYCLOHEXIMIDE; CYSTEINE ENDOPEPTIDASES; EGG PROTEINS; EXTRACELLULAR SPACE; FEMALE; GOLGI APPARATUS; H-2 ANTIGENS; HYDROGEN-ION CONCENTRATION; MACROMOLECULAR SUBSTANCES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIENZYME COMPLEXES; OVALBUMIN; PHAGOCYTOSIS; PINOCYTOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SYNTHESIS INHIBITORS; TUMOR CELLS, CULTURED; VACUOLES; VIRULENCE FACTORS, BORDETELLA;

EID: 0033558130     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompalibility complex. Annu. Rev. Immunol. 14:369.
2. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class-I restricted CTL responses to exogenous antigens. Immunity 5:295.
3. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 3:131.
4. Watts, C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:821.
5. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942.
6. Kovacsovics-Bankowski, M., and K. L. Rock. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented by MHC class I molecules. Science 267:243.
7. Reis e Sousa, C., and R. N. Germain. 1995. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182:841.
8. Norbury, C. C., L. J. Hewlett, A. R. Prescott, N. Shastri, and C. Watts. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783.
9. Norbury, C. C., B. J. Chambers, A. R. Prescott, H.-G. Ljunggren, and C. Watts. 1997. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:280.
10. Brossart, P., and M. J. Bevan. 1997. Presentation of exogenous antigens by major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90:1594.
11. Draper, R. K., and M. I. Simon. 1980. The entry of diphtheria toxin into mammalian cell cytoplasm: evidence for lysosomal involvement. J. Cell Biol. 87:849.
12. Hazes, B., and R. J. Read. 1997. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter in target cells Biochemistry 36:11051.
13. Confer, D. L., and J. W. Eaton. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948.
14. Glaser, P., H. Sakamoto, J. Bellalou, A. Ullmann, and A. Danchin. 1988. Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis. EMBO J. 7:3997.
15. Rogel, A., J. E. Schultz, R. M. Brownlie, J. G. Coote, R. Parton, and E. Hanski. 1989. Bordetella pertussis adenylate cyclase: purification and characterization of the toxin form of the enzyme. EMBO J. 8:2755.
16. Mock, M., and A. Ullmann. 1993. Calmodulin-activated bacterial adenylate cyclases as virulence factors. Trends Microbiol. 5:187.
17. Greenlee, D. V., T. J. Andreasen, and D. R. Storm. 1982. Calcium-independent stimulation of Bordetella pertussis adenylate cyclase by calmodulin. Biochemistry 21:2759.
18. Wolff, J., G. H. Cook, A. R. Goldhammer, and S. A. Berkowitz. 1980 Calmodulin activates prokaryotic adenylate cyclase. Proc. Natl. Acad. Sci. USA 77:3841.
19. Ladant, D. 1988. Interaction of Bordetella pertussis adenylate cyclase with calmodulin: identification of two separated calmodulin-binding domains. J. Biol. Chem. 267:2244.
20. Hanski, E., and Z. Farfel. 1985. Bordetella pertussis invasive adenylate cyclase: partial resolution of its cellular penetration. J. Biol. Chem. 260:643.
21. Hanski, E. 1989. Invasive adenylate cyclase toxin of Bordetella pertussis. Trends Biochem. Sci. 14:459.
22. Gordon, V. M., S. H. Leppla, and E. L. Hewlett. 1988. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 56:1066.
23. Gordon, V. M., W. J. Young. S. M. Lechler, M. C. Gray, S. H. Leppla, and E. L. Hewlett. 1989. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis: different processes for interaction with and entry into target cells. J. Biol. Chem. 264:14792.
24. Bellalou, J., H. Sakamoto, D Ladant, C. Geoffrey, and A. Ullmann. 1990. Deletion affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect. Immun. 58:3242.
25. Rogel, A., and E. Hanski. 1992. Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. J. Biol. Chem. 267: 22599.
26. Donovan, M. G., and D. R. Storm. 1990. Evidence that the adenylate cyclase secreted from Bordetella pertussis does not enter animal cells by receptor-mediated endocytosis. J. Gen. Physiol. 145:444.
27. Gentile, F., A. Raptis, L. G. Knipling, and J. Wolf. 1988. Bordetella pertussis adenylate cyclase: genetration into host cells. Eur. J. Biochem. 175:447.
28. + cytotoxic T cells. Infect. Immun. 63:3851.
29. + T cell epitopes. J. Immunol. 156:4697.
30. + epitope from lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. USA 94:3314
31. + T cells. Cell 71:1205.
32. Ladant, D., P. Glaser, and A. Ullmann. 1992. Insertional mutagenesis of Bordetella pertussis adenylate cyclase. J. Biol. Chem. 267:2244.
33. Karttunen, J., S. Anderson, and N. Shastri. 1992. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T cell antigens. Proc. Natl. Acad. Sci. USA 89:6020.
34. Girolomoni, G., M. Lutz, S. Pastore, C. U. Assman, A. Cavani, and P. Ricciardi-Castagnoli. 1995. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. Eur. J. Immunol. 25:2163.
35. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony stimulating factor. J. Exp. Med. 176:1693.
36. Goldberg, A. L., and K. L. Rock. 1992. Proteolysis, proleasomes and antigen presentation. Nature 357:375.
37. Rock, K. L., C. Gramm, L. Rothslein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. Goldberg. 1994. Inhibitors of the proteasome block the degradation of host cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell 78:761.
38. Craiu, A., M. Gaczynska, T. Atopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock. 1997. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 20: 13437.
39. Yewdell, J. W., and J. R. Benninck. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244:1072.
40. Craiu, A., T. Akopian, A. Goldberg, and K. L. Rock. 1997. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl Acad. Sci. USA 94:10850.
41. Donnelly, J. J., J. B. Ulmer, L. A. Hawe, A. Friedmanz, X. P. Shi, K. R. Leander, J. W. Shiver, A. I. Oliff, D. Martinez, D. Montgomery, and M. Liu. 1993. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA 90:3530.
42. Ulmer, J. B., J. J. Donnelly, and M. Liu. 1994. Presentation of an exogenous antigen by major histocompatibility complex class I molecules. Eur. J. Immunol. 24:1590.
43. Ballard, J. D., R. J. Collier, and M. N. Stambach. 1996. Anthrax toxin-mediated delivery of a cytotoxic T cell epitope in vivo. Proc. Natl. Acad. Sci. USA 94: 12059.
44. Ballard, J. D., A. M. Doling, K. Beauregard, R. J. Collier, and M. N. Stambach. 1998. Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin. Infect. Immun. 66:615.
45. Goletz, T., K. R. Klimpel, N. Arora, S. H. Leppla, J. M. Keith, and J. A. Berzofsky. 1997. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein. Proc. Natl. Acad. Sci. USA 94:12059.
46. Hackett, M., L. Guo, J. Shabanowitz, D. F. Hunt, and E. L. Hewlett. 1994. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science 266:459.
47. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
48. Goodwin, M. S., and A. A. Weiss 1990. Adenylate cyclase toxin is critical for colonization and pertussis toxin for lethal infection by Bordetella pertussis in infant mice. Infect. Immun. 58:3445.
49. Gross, M. K., O. A. Douglas, A Smith, and D. R. Storm. 1992. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional CyaA toxin of Bordetella pertuwis abolish virulence. Proc. Natl. Acad. Sci. USA 89:4898.
50. Guiso, N., M. Rocancourt, M. Szatanic, and J. M. Alonso. 1989. Bordetella adenylate cyclase is a virulence associated factor and a protective antigen. Mol. Pathog. 7:373.
51. Guiso, N., M. Szatanic, and M. Roeancourt. 1991. Protective activity of Bordetella adenylate cyclase against bacterial colonization. Microb. Pathog. 11:423.
52. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399.